Target intelligence / Profile preview

tRNA methyltransferase 1-like protein (TRMT1L)

Target
TRMT1L
Molecular classification
Enzyme, Methyltransferase, RNA-modifying enzyme
01

Overview

tRNA methyltransferase 1-like protein (TRMT1L) is an RNA-modifying enzyme that specifically dimethylates a guanine residue at position 27 of tyrosine tRNA (tRNA^Tyr) using S-adenosyl-L-methionine as the methyl group donor[1][2][4]. This modification, N2,N2-dimethylguanosine (m^2,2G), is critical for the stability and translational function of tRNA, particularly for tyrosine and serine codons[1]. TRMT1L is also required for maintaining another modification, acp3U, in the D-loop of several cytoplasmic tRNAs. Loss of TRMT1L activity results in reduced levels of certain tRNAs and is linked to impaired neuronal function and developmental disorders in humans; mouse models show that the gene is involved in motor coordination and postnatal brain function[1][2]. The enzyme operates in parallel with its paralog, TRMT1, which modifies a nearby guanine at position 26 of tRNA^Tyr[1]. No direct drug interactions or biomarker roles are currently described for TRMT1L.

Other names
tRNA (guanine(27)-N(2))-dimethyltransferaseTRMT1LC1orf25TRM1LMSTP070TRMT1-like proteintRNA methyltransferase 1-like proteinTRM1-likebG120K12.3TRM1 tRNA methyltransferase 1-liketRNA methyltransferase 1 homolog-liketRNA methyltransferase 1 like
02

Biological functions

RNA modification (specifically, dimethylation of guanine at position 27 in tRNA^Tyr)Maintenance of 3-(3-amino-3-carboxypropyl)uridine (acp3U) in the D-loop of tRNAstRNA stability and functionRegulation of efficient mRNA translation
03

Disease associations

Neurodevelopmental diseaseDisorders involving tRNA modification deficiencyPotential roles in neurological functions and coordination (supported by mouse models)
04

Safety considerations

No specific safety concerns or therapeutic challenges are reported; deficiency leads to tRNA instability and possible neurodevelopmental disease

Beyond the preview

Go deeper on tRNA methyltransferase 1-like protein (TRMT1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA methyltransferase 1-like protein (TRMT1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call